<?xml version="1.0" encoding="UTF-8"?>
<p>Similar to tocilizumab, sarilumab-treated patients are at an elevated risk of developing severe opportunistic infections that may result in hospitalization or death [
 <xref rid="B95-pharmaceuticals-13-00096" ref-type="bibr">95</xref>].
</p>
